The Biospecimen and Tissue Pathology Shared Resource at the Stephenson Cancer Center provides the following services to members and other interested investigators:
Types and availability of samples differ by organ type. Users are encouraged to contact the core for more information. If appropriate specimens are not available in the Biospecimen Bank, Core staff will help facilitate the procurement of specimens from the appropriate sources. The core also supports protocol-driven specimen collection for specific research projects.
The Biospecimen and Tissue Pathology Shared Resource was established in 2006 when the Stephenson assumed management of the Dawn Hope Tissue Bank, a large collection of gynecologic tissue samples. Since that time the Core has provided specimen collection, storage and processing services to members and other investigators.
The core’s biospecimen bank currently contains over 30,000 aliquoted samples collected since 2008, including tissue, blood, plasma, serum, cell and buccal samples. The Core utilizes an IRB-approved Universal Consent that allows patients at the Stephenson Cancer Center, OU Physicians or University of Oklahoma Medical Center to donate tissue or blood to the Biospecimen Bank. Over 3,500 patients have consented to participate since 2008. The Core has especially large specimen collections of gynecologic cancers and pancreatic cancer to support research in those disease sites.
The core also provides specimen collection, processing and shipping services to a large and active clinical research program at the Stephenson Cancer Center.
Since 2008 the Core has supported over 300 clinical trials, including large tissue trials such as GOG 136, GOG 210, GOG 221 and NCI’s SUCCEED trial, for which the SCC was the lead tissue site in each. A dedicated PK processing room supports the cancer center's phase I clinical trials program.
In 2012, the Stephenson Cancer Center was selected as a Tissue Source Site for The Cancer Genome Atlas (TCGA) Project. TCGA researchers are identifying the genomic changes in more than 20 different types of human cancer. By comparing the DNA in samples of normal tissue and cancer tissue taken from the same patient, researchers can identify changes specific to that particular cancer. By connecting specific genomic changes with specific outcomes, researchers will be able to develop more effective, individualized ways of helping each cancer patient.
In conjunction with the Clinical Trials Office, the Biospecimen and Tissue Pathology Shared Resource uses a HIPAA and 21 CFR Part 11 compliant clinical trials management system (Velos eResearch). An integrated specimen inventory system (Velos eSample) is used to catalog banked specimens. Data is stored on a secure server with access limited to key protocol personnel.
Your feedback on our Shared Resources is important, and we ask that you submit the following form.Complete the Feedback Form
TSET Health Promotion Research Center at OU Health Stephenson Cancer Center and Freedom Oklahoma, a statewide LGBTQ2S+ serving organization, are ...
Oklahoma Children’s Hospital OU Health is making it more convenient for high risk pregnant women and children to receive specialty care. Oklahoma ...
Blue Cross and Blue Shield of Oklahoma (BCBSOK) and OU Health, are pleased to announce that they have signed a new agreement that champions a positive ...